LTB4 Activates the MAP Kinase Pathway in Endothelial Cells to Cause Long‐Lasting Neutrophil Tethering, MCP ‐1 and NO Releases
Scandinavian Journal of Immunology · 2026
DOI: 10.1111/sji.70083 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scandinavian Journal of Immunology, 2026. Verfasst von Anne-Sofie Johansson und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center for Hematology and Regenerative Medicine, Stockholm, Sweden. Hauptthemen laut MEDLINE: Leukotriene B4, Neutrophils, Human Umbilical Vein Endothelial Cells, Chemokine CCL2. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vetenskapsrådet.
Abstract (Originalsprache)
Leukotriene B 4 (LTB 4 ), a potent chemotactic and immune‐modulating eicosanoid, signals via two receptors (BLT 1 and BLT 2 ), leading to rapid but transient migratory, adhesive and secretory responses in phagocytes. Previously, we reported that BLT 1 is the predominating BLT in human umbilical vein endothelial cells (HUVEC). However, little is known about how ligation of these receptors affects adhesive and secretory endothelial responses over time. Here, we demonstrate that in HUVEC, LTB 4 dose‐dependently and stereospecifically causes a biphasic tethering of neutrophils, where the second phase is robust, similar to that induced by lipopolysaccharide, and persists for 3–8 h. LTB 4 also causes up‐regulation of E‐selectin, ICAM‐1 and VCAM‐1 and release of MCP‐1 and nitric oxide (but not of IL‐8 or HMGB1). These responses appeared to be mediated via BLT 1 and BLT 2 as judged by BLT 1 shRNA gene silencing and/or treatment with BLT 1 and BLT 2 specific antagonists prior to LTB 4 activation of HUVEC. Moreover, LTB 4 responses used primarily the MAP kinase/Erk pathway. Our findings suggest a new role for LTB 4 not only in early but also in late vascular inflammatory responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Hematology and Regenerative Medicine, Stockholm, Sweden.
- Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
- Department of Medical Biochemistry and Biophysics, Division of Chemistry II, Karolinska Institutet, Stockholm, Sweden.
ORCID-Profile: Anne-Sofie Johansson
Förderung
- Vetenskapsrådet
Zitieren
APA
Johansson, A. S., Haeggström, J. Z., & Palmblad, J. (2026). LTB4 Activates the MAP Kinase Pathway in Endothelial Cells to Cause Long‐Lasting Neutrophil Tethering, MCP ‐1 and NO Releases. Scandinavian Journal of Immunology. https://doi.org/10.1111/sji.70083
Vancouver
Johansson AS, Haeggström JZ, Palmblad J. LTB4 Activates the MAP Kinase Pathway in Endothelial Cells to Cause Long‐Lasting Neutrophil Tethering, MCP ‐1 and NO Releases. Scandinavian Journal of Immunology. 2026. doi:10.1111/sji.70083
BibTeX
@article{Johansson2026,
author = {Johansson, Anne-Sofie and Haeggström, Jesper Z and Palmblad, Jan},
title = {LTB4 Activates the MAP Kinase Pathway in Endothelial Cells to Cause Long‐Lasting Neutrophil Tethering, MCP ‐1 and NO Releases},
journal = {Scandinavian Journal of Immunology},
year = {2026},
doi = {10.1111/sji.70083}
}
EUVIMED